Pricing of pharmaceuticals is becoming a major challenge for health systems

Pricing of pharmaceuticals is becoming a major challenge for health systems

Manufacturers using their market power to maximise profits results in prices that are unjustifiable and unaffordable, argue Steven Morgan and colleagues

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ (Online) 2020-01, Vol.368, p.l4627-l4627, Article 4627
Hauptverfasser: Morgan, Steven G, Bathula, Hannah S, Moon, Suerie
Format: Artikel
Sprache:eng
Schlagworte:
Consumption
Costs
Delivery of Health Care - economics
Drug Costs - statistics & numerical data
Drug Costs - trends
Drug Development - economics
Drug Industry - economics
Drugs
Expenditures
FDA approval
General & Internal Medicine
Hepatitis
Humans
Innovations
Life Sciences & Biomedicine
Manufacturers
Medicine, General & Internal
Organizational Innovation
Patents as Topic
Patients
Pharmaceutical industry
Pharmaceutical Preparations - economics
Pharmaceutical Research - economics
Prices
R&D
Research & development
Science & Technology
Technological change
Trends
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Manufacturers using their market power to maximise profits results in prices that are unjustifiable and unaffordable, argue Steven Morgan and colleagues
ISSN:0959-535X
0959-8146
1756-1833
1756-1833
DOI:10.1136/bmj.l4627